| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,477 |
1,322 |
$228K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
432 |
387 |
$156K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,157 |
1,849 |
$141K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,167 |
1,850 |
$46K |
| 87631 |
|
272 |
262 |
$37K |
| 87500 |
|
1,287 |
1,117 |
$31K |
| 87640 |
|
906 |
818 |
$21K |
| 87581 |
|
642 |
599 |
$20K |
| 87486 |
|
630 |
587 |
$20K |
| 87481 |
|
341 |
321 |
$17K |
| 87653 |
|
770 |
704 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
578 |
538 |
$7K |
| 87529 |
|
87 |
76 |
$5K |
| 87641 |
|
360 |
351 |
$5K |
| 87511 |
|
111 |
101 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
87 |
80 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
89 |
80 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
70 |
64 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
15 |
14 |
$1K |
| 87563 |
|
18 |
17 |
$561.44 |